Tuesday, November 27, 2012

Health - Google News: Gilead hepatitis C drug shows promise in late-stage trial - Reuters

Health - Google News
Google News
Gilead hepatitis C drug shows promise in late-stage trial - Reuters
Nov 27th 2012, 14:53


Gilead hepatitis C drug shows promise in late-stage trial
Reuters
Tue Nov 27, 2012 9:36am EST. (Reuters) - Gilead Sciences said a late-stage trial of its experimental hepatitis C treatment showed that the virus was not detected in 78 percent of patients taking the drug, 12 weeks after completing therapy. The trial, named ...
Gilead gallops to first Ph3 success for all-oral hepatitis C drug programFierceBiotech
Gilead Hep C Drug Meets Expectations In Phase 3 TrialInvestor's Business Daily
Gilead Sciences Scores First Win With Late-Stage Hep C StudyTheStreet.com
4-traders -Benzinga
all 29 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

0 comments:

Post a Comment

Twitter Delicious Facebook Digg Stumbleupon Favorites More